Hip Pain Chronic Clinical Trial
— HIPSTEROfficial title:
Patients With Longstanding HIP and Groin Pain Referred to Orthopedic Care: Effectiveness of Education and exerciSe ThERapy (HIPSTER)
Longstanding hip and groin pain (LHGP) is a common and debilitating problem in young to middle aged individuals. These patients often get referred to orthopedic departments. Consensus statements on the management of these patients commonly recommend a physical therapist-led intervention as the first line intervention. However, the optimal content and delivery of this intervention is currently unknown. In this study we will compare the effectiveness of usual care (unstructured physical therapist-led intervention) to a semi-structured, progressive individualized physical therapist-led intervention on hip-related quality of life in people with longstanding hip and groin pain referred to an orthopedic department.
Status | Recruiting |
Enrollment | 122 |
Est. completion date | December 1, 2030 |
Est. primary completion date | May 1, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 55 Years |
Eligibility | Inclusion Criteria: - Men and women aged 18-55 years - Referred to the Dept of Orthopedics due to hip and/or groin pain - Activity-related unilateral or bilateral groin pain >3 months - Pain reproduced with the FADIR test. Exclusion Criteria: - Groin pain originating from any diagnosis with other treatment pathways, i.e., i) Acute traumatic hip injuries (such as hip dislocation, hip fractures); ii) Verified moderate or severe OA (Tönnis grade >1); iii) Palpable hernia; iv) Low-back pain with a positive straight leg raise test and/or hip and groin pain provoked primarily by repeated motions of the lumbar spine; v) Sacroiliac joint pain with thigh thrust test. - Co-morbidities potentially interfering with treatment, i.e., i) Co-morbidities overriding the hip and groin-related symptoms and dysfunction (such as other acute lower limb injuries, rheumatoid arthritis etc), ii) Co-morbidities prohibiting physical activity and training (heart disease etc), iii) Current psycho-social disorders requiring treatment. - Other: i) History of drug abuse within the last year; ii) Not understanding the language of interest (Scandinavian languages, or English). |
Country | Name | City | State |
---|---|---|---|
Sweden | Skane University Hospital | Malmö |
Lead Sponsor | Collaborator |
---|---|
Lund University |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Qualitative interviews - Patients | A sub-group of participants (about 10 or until saturation) will be interviewed in a semi-standardised fashion, about their experiences of undergoing the intervention. | The interviews will be conducted between 4 months and 6 months after baseline. | |
Other | Qualitative interviews - Physical therapists | Physical therapists trained in delivering the intervention in the experimental arm will be interviewed in a semi-standardised fashion, about their experiences of treating this patient population and their experience of delivering the experimental intervention. | The interviews will be conducted during active data collection, when clinicians have treated a minimum of 3 patients in the trial, with an estimated average of 6 months after data collection has started. | |
Primary | Change in iHOT-33 scores at 4 months | iHOT-33 is a 33 question self-reported outcome scale, measuring hip-related quality of life. This outcome measure has been validated and translated to Swedish. The scores are summed on a 0 (worst)-100 (best) scale. | The primary outcome will be collected at baseline and at the primary end-point (4 months after baseline). | |
Secondary | Change in iHOT-33 scores at 1, 2 and 5 years | iHOT-33 is a 33 question self-reported outcome scale, measuring hip-related quality of life. This outcome measure has been validated and translated to Swedish. The scores are summed on a 0 (worst)-100 (best) scale. | This outcome will be collected at baseline and 1,2 and 5 years after baseline. | |
Secondary | Patient acceptable symptom state (PASS) | The patient acceptable symptom state (PASS) will be collected using a dichotomized question ("Taking into account your hip and groin function and pain, and how it affects your daily life, including your ability to participate in sport and social activities, do you consider that your current state is acceptable if it remained like that for the rest of your life?"). | This outcome will be collected at the primary endpoint (4 months after baseline). In addition it will also be collected at 1,2 and 5 years after baseline. | |
Secondary | Treatment failure | Treatment failure will be collected using a dichotomized question "Do you consider your current state so unsatisfactory that you think your treatment has failed?". | This outcome will be collected at the primary endpoint (4 months after baseline). In addition it will also be collected at 1,2 and 5 years after baseline. | |
Secondary | Perceived symptom improvement | Perceived symptom improvement will be collected using a 7-point Global rating of change (GROC) scale, ranging from -3 (a lot worse), to +3 (a lot better). | This outcome will be collected at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline. | |
Secondary | Patient desire and beliefs regarding surgical intervention | Patient desire and beliefs regarding surgical intervention will be collected using two dichotomized questions; "Do you want to undergo surgery?" and "Do you believe surgery is needed for you to get better?". | This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline. | |
Secondary | Physical activity | Physical activity and return to sport/exercise will be collected using questions based on the Swedish National Board of Health and Welfare (Socialstyrelsen) physical activity screening, a self-reported measure of minutes spent doing strenuous and everyday activities. | This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline. | |
Secondary | Pain catastrophizing | Pain catastrophizing will be measured with the Pain Catastrophizing Scale (PCS), a valid patient-reported outcome with 13 items. It is scored 0 to 52, with higher values indicating higher degrees of catastrophizing. | This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline. | |
Secondary | Pain self-efficacy | Pain-related self-efficacy will be collected with the short-form Pain Self-efficacy Questionnaire (PSEQ-2), a commonly used measure of self-efficacy in musculoskeletal pain. PSEQ-2 consists of 2 questions. It is scored 0 to 12, with higher score indicating a greater degree of pain self-efficacy. | This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline. | |
Secondary | Health related quality of life | Generic health-related quality of life will be measured using EQ5D. It is scored from 0 to 1, where 1 corresponds to perfect health, and is available in Swedish. | This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline. | |
Secondary | Employment status | Employment status will be measured using a Likert scale, from unemployed, student, part time work, full time work or retired. | This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline. | |
Secondary | Surgical interventions | Any performed surgical interventions to the hip and/or groin region will be collected from medical records and self-reported questions. | This outcome will be collected from medical records at 1, 2 and 5 years. | |
Secondary | Osteoarthritis development | The presence of narrowing joint space will be measured using Tönnis grade, measured on an AP radiograph. | This measure will be collected at baseline, and at 2 and 5 year follow ups. | |
Secondary | Usual care content | Any physical therapist-led intervention in the usual care group will be collected using self-reported questions regarding volume (number of sessions), content (overall focus of intervention) and adherence (patient compliance to prescribed intervention). | This outcome will be collected from the usual care group, after the primary end-point at 4 months. | |
Secondary | Hip range of motion | Hip range of motion (in degrees) will be measured with a digital inclinometer in internal rotation in 90° of hip flexion and zero° flexion. | This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline. | |
Secondary | Isometric hip muscle force production | Isometric hip muscle force production will be measured (in Newton and nm/kg) with a belt-fixated handheld dynamometer for hip adduction, flexion and hip extension. | This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline. | |
Secondary | Hop performance | Hop performance will be assessed using the single leg hop for distance test. Distance (cm) and kinematics (joint angles) and forces (joint moments) will be measured. | This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline. | |
Secondary | Y-balance test | Single leg balance will be assessed using the Y-balance test. Distance (cm) and Limb symmetry index will be collected. | This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline. | |
Secondary | Single leg balance | Single leg balance will be evaluated by postural sway using markers, 3D-motion capture and force plates. | This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline. | |
Secondary | Single leg squat | Single leg squat performance will be evaluated using markers, 3D-motion capture and force plates to calculate kinematics (joint angles) and kinetics (joint moments) related to the task. | This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline. | |
Secondary | Step down | Step down performance will be evaluated using markers, 3D-motion capture and force plates to calculate kinematics (joint angles) and kinetics (joint moments) related to the task. | This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline. | |
Secondary | Rear foot elevated split squat jump | Lower body power will be evaluated using markers, 3D-motion capture and force plats to collect kinematics (joint angles) and kinetics (joint moments) during the task. | This outcome will be collected at baseline and at the primary endpoint (4 months after baseline). In addition it will also be collected at 1 year after baseline. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03590145 -
Reliability of the Doha Agreement Classification of Groin Pain
|
||
Completed |
NCT06083428 -
Erector Spinae vs. PENG Block for Total Hip Arthroplasty
|
Phase 4 | |
Completed |
NCT05551000 -
Functional Training to Improve Everyday Performance in Elderlies
|
N/A | |
Completed |
NCT04289922 -
Validation of the Norwegian VISA-G Questionnaire
|
||
Recruiting |
NCT05868369 -
The Effectiveness of Immersive Virtual Reality as a Pain Control Modality After Hip Arthroscopy
|
N/A | |
Completed |
NCT04211987 -
Fast Track Total Hip Arthroplasty vs Standard Care
|
N/A | |
Recruiting |
NCT04736641 -
Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire
|
||
Completed |
NCT02947178 -
Hip Arthroscopy Pain Control Randomized Control Trial (RCT)
|
Phase 4 | |
Recruiting |
NCT03985280 -
Radiofrequency Versus Intraarticular Local Anesthestic and Steroids Injection for Chronic Hip Pain.
|
Phase 4 | |
Completed |
NCT05944380 -
PENG Block for Total Hip Arthroplasty
|
Phase 4 | |
Completed |
NCT05261009 -
PENG Block Versus LP Block for THA Postop Pain
|
Phase 4 | |
Recruiting |
NCT05022381 -
Treatment of Chronic Hip Pain by Application of Conventional Radiofrequency Thermocoagulation to the Articular Branches of the Femoral and Obturatory Nerve
|
N/A | |
Completed |
NCT03248934 -
Patient Performed Examination for Patients With Intra-articular Hip Pain
|
N/A | |
Completed |
NCT03720821 -
Cognitive Flexibility Training for Persistent Pain: Neuroimaging Pilot (COFLEX-i)
|
N/A | |
Completed |
NCT04393909 -
Improving Safety of Diagnosis and Therapy in the Inpatient Setting
|
N/A | |
Recruiting |
NCT04027140 -
MDR - M/L Taper With Kinectiv Technology Stems and Necks
|
||
Recruiting |
NCT03490071 -
Long-term Follow up of Patients With Longstanding Hip and Groin Pain
|
||
Recruiting |
NCT04028687 -
MDR - PMCF Study for Taperloc Complete Stems
|
||
Recruiting |
NCT03576625 -
Effect of Buglossoides Oil on Recent Chronic Non-injurious Hip and Knee Pain
|
Phase 1 | |
Recruiting |
NCT06221709 -
Continuous Radiofrequency in Hip Osteoarthritis Pain: A Randomized Clinical Trial.
|
N/A |